TrialPloS one2018

Albuminuria during treatment with angiotensin type II receptor blocker is a predictor for GFR decline among non-diabetic hypertensive CKD patients.

Mi-Yeon Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.